Protagonist Therapeutics Peptide Platform: The Journey from De Novo Discovery to Phase 3 Clinical Development Programs

Time: 3:30 pm
day: Conference Day 1

Details:

• De novo peptide discovery methods highlighting our clinical programs, in particular the J&J collaboration on JNJ-2113

• Peptide optimization strategies

• Lessons learned to be applied to future targets

Speakers: